You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Home
About
Announcements
OCRINT
Nominated Principal Investigators
Our Team
Events
Research Projects
Currently selected
SCCONE
Demonstration Projects
Asset Mapping of Substance Use Prevention and Intervention Programs and Services
Surviving Opioid Overdose with Naloxone Education and Resuscitation
Northern Ontario Drug Use and Service Needs Assessment (NODUS)
Youth Substance Use Service Provider Study
Identifying Service Needs among PWUD
Community-Based Competition Grants
SSP Environmental Scan
COVID-19 Research Projects
Section 56 Consultation
Follow-Up Study of Federal Inmates on Opioid Agonist Treatment in Ontario
Ontario-Based Residential Treatment Environmental Scan
COVID-19 Vaccine Confidence Among PWUD
Sudbury Supervised Consumption Site Evaluation
PWLE National Working Group
Cannabis Projects
BC Decriminalization Policy Evaluation
Nominal Group Technique (NGT) Board
Advisory Board
People Who Use Drugs (PWUD) Qualitative Study
Qualitative Police Study
Quantitative Health and Police Data Analyses
Impact on General Public
Health Service Systems
Economic Impacts
Knowledge Validity and Triangulation
Decriminalization Evaluation Publications and Reports
Research Team
Working Groups
National Projects
Implementation Science Program
Naloxone Distribution
Detoxification and Withdrawal Management
Corrections Projects
National Safer Supply Evaluation
Clinical Trials
ASCME
OPTIMA
Knowledge Transfer
Academic Journal Articles
Reports
Guidance Documents
COVID-19 Rapid Guidance
Contingency Management
Injectable OAT
Lower Risk Cannabis Use Guidelines
Supervised Consumption Services
Take-home Naloxone Distribution
Alcohol Use Disorder (AUD) Guidelines
Detoxification and Withdrawal Management
Lower-Risk Cannabis Use Guidelines for Psychosis
Workshops
Contact Us
Integrated Relapse Prevention Treatment Pathway for Women with Alcohol Misuse Integrated Anti-Craving Medications Plus Counselling for Women in Community Substance Misuse Services
Page Content
PI and project team:
Yoon, R., Furlong, A., Coombs, M., Bloomenfeld, J., & Dave, S.
Women with substance use disorder (SUD) face significant stigma and barriers in accessing anti-craving medications such as Naltrexone and Acamprosate. Currently access to anti-craving medications from a health care provider is not commonly available to women in community based substance misuse treatment programs in Ontario. Therefore, this pilot project, delivered by nurse practitioners, fills the important service gap in gender-responsive and trauma-informed substance misuse and primary health care for women. The goal of the program is to support long-term recovery for adult women with SUD by integrating access to anti-craving medications with access to counselling delivered through the Jean Tweed Centre from across the province. An evaluation component will measure the impacts of the service on specific indicators of recovery, client’s perceptions of the service, and barriers and enablers to successful implementation. This project will share and translate knowledge and evidence related to interventions for substance misuse towards improved programs and systems in the province for women with SUD. It will also enhance collaboration and communication between researchers, service providers, policy makers, and those with lived experience
.